Skip to content

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and diabetes-a Multicenter Retrospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07082933
Enrollment
5000
Registered
2025-07-24
Start date
2025-08-01
Completion date
2027-12-31
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Arterial Hypertension (PAH)

Keywords

Pulmonary arterial hypertension, Diabetes, Mortality

Brief summary

This is a multicenter retrospective cohort study on pulmonary arterial hypertension. It is expected to collect data from no less than 5,000 patients to compare the long-term overall survival of patients with and without diabetes, and analysis the risk factors of the overall survival .

Interventions

OTHERStandard medical treatment

Standard medical treatment

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Individuals aged 18 to 80 years with full capacity for civil conduct. * Patients diagnosed with pulmonary hypertension by community-level and/or higher-level medical institutions.

Exclusion criteria

* Patients with malignant tumors. * Other physical conditions judged by the researchers as making the patients ineligible to participate in the clinical study.

Design outcomes

Primary

MeasureTime frameDescription
Overall Survival10 yearsTime from diagnosis of pulmonary hypertension to death

Secondary

MeasureTime frame
Pulmonary Artery Pressure(PAP)baseline

Other

MeasureTime frame
Brain natriuretic peptidebaseline
blood glucosebaseline

Contacts

Primary ContactYue Zhang, Doctor
zhangy718@foxmail.com0086+13022957751

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026